Umb Bank, N.A. Karuna Therapeutics, Inc. Transaction History

Umb Bank, N.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$164.66 - $218.08 $658 - $872	-4 Reduced 0.84%	475 $80,000
Q2 2023 Jul 25, 2023	BUY	$176.32 - $240.22 $705 - $960	4 Added 0.84%	479 $103,000
Q1 2023 Apr 11, 2023	SELL	$161.33 - $204.36 $12,099 - $15,327	-75 Reduced 13.64%	475 $86,000
Q4 2021 Feb 09, 2022	BUY	$110.64 - $159.4 $60,852 - $87,670	550 New	550 $72,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Umb Bank, N.A. with notifications on news.